IDEXX Laboratories (IDXX) 10-K Summary — Year Ended Dec 31, 2025
The filing provides revenue and profitability metrics for the fiscal year. No business description or risk factors are included in the supplied sections.
Key takeaway
Year ended Dec 31, 2025 · FY2025 10-K
The filing provides revenue and profitability metrics for the fiscal year. No business description or risk factors are included in the supplied sections.
Financial snapshot
Selected annual figures reported with the filing, shown separately from the narrative summary.
Annual revenue
$4.3B
Revenue reported for the fiscal year.
Operating income
$1.4B
Income from operations reported for the year.
Net income
$1.1B
Net income reported for the year.
Operating cash flow
$1.2B
Cash generated by operating activities.
Annual revenue trend
Reported annual revenue and its change from the preceding fiscal year.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2022 | $3.4B | +4.7% |
| Dec 31, 2023 | $3.7B | +8.7% |
| Dec 31, 2024 | $3.9B | +6.5% |
| Dec 31, 2025 | $4.3B | +10.4% |
Business overview
The supplied filing sections do not contain a description of the company's business.
Financial performance
Revenue increased each year over the reported period, with the latest year's growth rate higher than the previous year. The company reported positive operating income, net income, and operating cash flow.
Material risks
No specific risk factors were provided in the supplied filing context.
Liquidity and capital
The liquidity and capital resources section references a prior filing, so no current details are available in this document.
What to watch
Monitor the revenue growth trajectory in the next filing.